期刊文献+

原发性醛固酮增多症致高血糖一例报告及探讨

原文传递
导出
摘要 原发性醛固酮增多症与糖代谢紊乱存在一定关系,其原因和机制目前尚未清楚.关于原发性醛固酮增多症合并糖尿病的总体治疗方法尚未有报道,患者血糖控制多不理想,常需要多种药物联合治疗。该患者应用螺内酯、格列美脲联合胰岛素综合治疗后,血糖控制理想,也减少了胰岛素用量及降糖药物种类,效果显著,特此报告以进一步探讨其机制。
出处 《实用糖尿病杂志》 2013年第4期22-24,共3页 Journal of Practical Diabetology
  • 相关文献

参考文献10

  • 1徐媛媛,王卫庆.原发性醛固酮增多症的发病机制[J].国际内分泌代谢杂志,2011,31(2):141-144. 被引量:1
  • 2Hiroi N, Sue M, Yoshibara A, et al. Prevalence of adrenalmasses in japanese patients with type 2 diabetes mellitus. Diabeto 1Metab Syndr 2010 ;2:71.
  • 3Colussi G, Catena C,Lapenna R,et al. Insulin resistance andhyperinsulinemia are related to plasma aldosterone levels in hyperten-sive patients. Diabetes Care 2007 ;30:2348 -2354.
  • 4周亚茹,曾正陪,张晶,童安莉,卢琳,宋爱羚,夏维波,付勇,姜艳,陈适,梁伟,茅江峰,张化冰,李伟.原发性醛固酮增多症的胰岛素抵抗及葡萄糖代谢异常[J].中华内分泌代谢杂志,2006,22(3):294-297. 被引量:26
  • 5Rowe JW, Tobin JD, Rosa RM, et al. Effect of experimentalpotassium deficiency on glucose and insulin metabolism. Metabolism1980 ;29 :498 -502.
  • 6张晶,曾正陪,周亚茹,童安莉,卢琳,宋爱玲,阎朝丽,陈适,梁伟,李玉秀,覃舒文.原发性醛固酮增多症中低血钾对糖代谢的影响[J].中国医学科学院学报,2006,28(6):745-749. 被引量:6
  • 7Delaunaru F, khan A, Cintra A, et al. Pancreatic p-cells areimportant targets for the diabetogenic dffedts of glucocorticoids. J ClinInvest 1997;100:2094 - 2098.
  • 8Sindelka G,Widimsky J,HaasT,et al. Insulin action in pirma-ry hyperaldosteronism before and after surgical or pharmacologicaltreatment. Exp Clin EndoeimolDiabetes 2000 ; 108:21 - 25.
  • 9KrausD,JagerJ,MeierB,etal. Aldosterone inhibits uncouplingProtein-1, induces insulin resistance, and stimulatse proinflammatory ad-ipokines in adipocytes. Horm Metab Rse 2005 ;37 :455 -459.
  • 10Nishizaka MK,Amin Zaman M,Green SA,et al. Impaired en-dothelium-deopendent flow-mediated vasodilation in hypertensive sub-jects with hyperaldosteronism. Circulation 2004 ; 109:2857 - 2861.

二级参考文献42

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3092
  • 2杨文英,杨兆军,李光伟,邢小燕.联合测量腰臀围比值(或腰围)和血压可预测代谢综合征[J].中华内分泌代谢杂志,2005,21(3):227-229. 被引量:92
  • 3杨文英.空腹血糖受损下限诊断切割点的建议[J].中华医学杂志,2005,85(28):1947-1950. 被引量:86
  • 4曾正陪 史轶蘩.多内分泌腺瘤病.协和内分泌和代谢学[M].北京:科学出版社,1999.1606-1621.
  • 5Mulatero P, Dluhy RG, Giacchetti G,et al. Diagnosis of primary aldosteronism from screening to subtype differentiation. Trends Endocrinol Metab ,2005,16 : 114-119.
  • 6Mulatero P. A New form of hereditary primary aldosteronism familial hyperaldosteronism type Ⅲ. J Clin Endocrinol Metab, 2008,93:2972-2974.
  • 7Davies E, Mackenzie SM, Freel EM, et al. Altered corticosteroid biosynthesis in essential hypertension A digenic phenomenon. Mol Cell Endocrinol,2009,300 : 185-191.
  • 8Freel EM, Ingrain M, Wallace AM, et al. Effect of variation in CYPllβ1 and CYPll132 on corticosteroid phenotype and hypotbalamicpituitaryadrenal axis activity in hypertensive and normotensive subjects. Clin Endocrinol (Oxf) ,2008,68:700-706.
  • 9Wang B,Zhang G, Ouyang J, et al. Association of DNA polymorphisms within the CYP11B2/CYP11 Bl locus and postoperativehypertension risk in the patients with aldosteroneprodueing adenomas. Urology ,2010,76 : 1018.
  • 10Lenzini L, Seccia TM, Aldighieri E, et al. Heterogeneity of aldosteroneproducing adenomas revealed by a whole transcriptome analysis. Hypertension ,2007,50 : 1106-1113.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部